Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

How I treat warm autoimmune hemolytic anemia

Wilma Barcellini, Bruno Fattizzo

Blood (2021) 137 (10): 1283–1294.

https://doi.org/10.1182/blood.2019003808

Published: 2021

Journal Articles

In Vivo reconstruction of Human Erythropoiesis with Circulating Mature Human RBCs in Humanized Liver Mistrg Mice

Yuanbin Song, MD, Liang Shan, PhD, Rana Gbyli, MS, Wei Liu, PhD, Xiaoying Fu, MD, Xiaman Wang, MD PhD, Ashley Qin, Amisha Patel, MS, Yimeng Gao, PhD, Toma Tebaldi, PhD, Giulia Biancon, PhD, David Urbonas, Jonathan Alderman, PhD, Stephanie Halene, MD, Richard Flavell, PhD

Blood (2019) 134 (Supplement_1): 338.

https://doi.org/10.1182/blood-2019-130701

Published: 2019

Journal Articles

Inhibition of C3 with APL-2 Results in Normalisation of Markers of Intravascular and Extravascular Hemolysis in Patients with Autoimmune Hemolytic Anemia (AIHA)

Federico Grossi, MD, Merrill Kingman Shum, MD, Morie A. Gertz, MD, Eloy Roman, MD, Pascal Deschatelets, PhD, Mohamed Hamdani, MS, Frank Stout, Cedric G Francois, MD PhD

Blood (2018) 132 (Supplement 1): 3623.

https://doi.org/10.1182/blood-2018-99-119468

Published: 2018

Journal Articles

Evaluating and Correcting Iron Deficit in Atypical Hemolytic Uremic Syndrome (HUS)

Samuel B Reynolds, MD BS, William Tse, MD

Blood (2018) 132 (Supplement 1): 5002.

https://doi.org/10.1182/blood-2018-99-112353

Published: 2018

Journal Articles

Short Course of Bortezomib in Anemic Patients with Refractory or Relapsed Cold Agglutinin Disease. a Phase II Prospective Study By the Gimema Group

Giuseppe Rossi, MD, Francesca Paoloni, Bruno Fattizzo, MD, Francesca Binda, MD, Mariella D'Adda, MD, Mirko Farina, MD, Cecilia Carbone, MD, Francesco Zaja, MD, Elisa Lucchini, MD, Francesca Romana Mauro, MD, Flavia Salvi, MD, Monia Marchetti, MD, Paola Fazi, Wilma Barcellini, MD

Blood (2017) 130 (Supplement 1): 2199.

https://doi.org/10.1182/blood.V130.Suppl_1.2199.2199

Published: 2017

Journal Articles

SCD-101: A New Anti-Sickling Drug Reduces Pain and Fatigue and Improves Red Blood Cell Shape in Peripheral Blood of Patients with Sickle Cell Disease

Robert Swift, PhD, Osheiza Abdulmalik, DVM, MS, Qiukan Chen, Toshio Asakura, MD PhD, Kelsey Gustafson, MS, James E Simon, PhD, Virdah Zaman, MS, Kevin Alexis Quiusky, MD, Kathryn L. Hassell, MD, Iuliana Shapira, MD, Gurinder Sidhu, MD, Tracian James-Goulbourne, MD, Kisha Carrington, MD, John Muthu, MD, Peter N Gillette, MD

Blood (2016) 128 (22): 121.

https://doi.org/10.1182/blood.V128.22.121.121

Published: 2016

Journal Articles

A Selective ORAL GLYT1 Inhibitor, Improves Anemia and RED CELL Survival in a MOUSE MODEL of Beta-Thalassemia

Carlo Brugnara, MD, Anja Harmeier, Lucia De Franceschi, MD, Alessandro Matte, Michael Winter, Annette Koerner, Omar Khwaja, Thomas Singer, Elisabetta Beneduce, Enrica Federti, Angela Siciliano

Blood (2016) 128 (22): 1284.

https://doi.org/10.1182/blood.V128.22.1284.1284

Published: 2016

Journal Articles

Complement Blockade with C1 Esterase Inhibitor in Severe C3d Positive Autoimmune Hemolytic Anemia

Jasmin Desai, MD, Catherine Broome, MD

Blood (2016) 128 (22): 4817.

https://doi.org/10.1182/blood.V128.22.4817.4817

Published: 2016

Journal Articles

Inflammasome-Dependent IL-1β Release from Neutrophils in Human Sickle Cell Anemia

Rafaela Mendonça, B.Sc., Angelica A. Silveira, M.Sc., Fernando Vieira Pericole, MD, Cecilia Seguin, B.Sc., Flavia C. Leonardo, PhD, Sara T Olalla Saad, MD, PhD, Fernando F. Costa, MD PhD, Nicola Conran, PhD

Blood (2016) 128 (22): 854.

https://doi.org/10.1182/blood.V128.22.854.854

Published: 2016

Journal Articles

GBT440, a Potent Anti-Sickling Hemoglobin Modifier Reduces Hemolysis, Improves Anemia and Nearly Eliminates Sickle Cells in Peripheral Blood of Patients with Sickle Cell Disease

Josh Lehrer-Graiwer, MDMPhil, FACC, Jo Howard, MD, Claire Jane Hemmaway, MD, Moji Awogbade, Paul Telfer, FRCPath,MD, Mark Layton, MB, FRCP, Timothy Mant, MB, FFPM, FRCP, Kobina Dufu, PhD, Athiwat Hutchaleelaha, PhD, Teri Koller, MBA, Donna Oksenberg, PhD, Mira Patel, PhD, Eleanor Ramos, MD

Blood (2015) 126 (23): 542.

https://doi.org/10.1182/blood.V126.23.542.542

Published: 2015

Journal Articles

Elevated Red Cell Microparticles (RMP) in Hematologic and Thrombotic Disorders

Wenche Jy, PhD, Gabriel Tinoco, MD, Mohamed EL Dinali, MD, Carlos Bidot, Jr., BS, Lawrence L Horstman, BS, Pamela Dudkiewicz, MSN, ARNP, Yeon-Soong Ahn, MD

Blood (2015) 126 (23): 3553.

https://doi.org/10.1182/blood.V126.23.3553.3553

Published: 2015

Journal Articles

IgG Alloantibodies Against RBC Induced By Pregnancy or Transfusion Have Unique Glycosylation Patterns Which Correlate with Clinical Outcome of Hemolytic Disease of the Fetus or Newborn

Myrthe Elisabeth Sonneveld, MD, Rosina Plomp, Jon Admiraal, Carolien Koeleman, Agnes Hipgrave-Ederveen, Joke Koelewijn, PhD, Peter Ligthart, Masja De Haas, Prof, MD, Manfred Wuhrer, Prof, C. Ellen Van der Schoot, Prof, MD, Gestur Vidarsson, PhD

Blood (2015) 126 (23): 660.

https://doi.org/10.1182/blood.V126.23.660.660

Published: 2015

Journal Articles

Complement Inhibition with Eculizumab in Patients with Cold Agglutinin Disease (CAD): Results from a Prospective Phase II Trial (DECADE Trial)

Alexander Röth, MD, Martin Bommer, MD, Andreas Hüttmann, MD, Dörte Herich-Terhürne, Nils Kuklik, PhD, Lenz Veronika, Hubert Schrezenmeier, MD, Ulrich Dührsen, MD

Blood (2015) 126 (23): 274.

https://doi.org/10.1182/blood.V126.23.274.274

Published: 2015

Journal Articles

End-Alveolar Carbon Monoxide As a Measure of Erythrocyte Survival and Hemolytic Severity in Sickle Cell Disease

Caterina P. Minniti, MD, John H. Baird, Dihua Xu, Laurel Mendelsohn, BS, Rehan Saiyed, B.S., Mary Jackson, RN, James Nichols, RN, Daniel Kim-Shapiro, PhD, Yang Xia, MD PhD, Gregory J. Kato, MD

Blood (2014) 124 (21): 2696.

https://doi.org/10.1182/blood.V124.21.2696.2696

Published: 2014

Journal Articles

Case Report: Autoimmune Hemolytic Anemia with Venous Thromboembolism, a Common Complication of a Rare Disease

Sonikpreet Sonikpreet, Gulshan Oberoi, Sarwan Kumar

Blood (2014) 124 (21): 4869.

https://doi.org/10.1182/blood.V124.21.4869.4869

Published: 2014

Journal Articles

TNT003, an inhibitor of the serine protease C1s, prevents complement activation induced by cold agglutinins

Ju Shi, Eileen L. Rose, Andrew Singh, Sami Hussain, Nancy E. Stagliano, Graham C. Parry, Sandip Panicker

Blood (2014) 123 (26): 4015–4022.

https://doi.org/10.1182/blood-2014-02-556027

Published: 2014

Includes: Supplemental data

Journal Articles

The Clinical Utility Of Next-Generation Sequencing In The Diagnosis Of Hereditary Hemolytic Anemias

Roberto H Nussenzveig, PhD, Nikhil Sangle, MD, Robert D. Christensen, MD, Mohamed E Salama, MD, Josef Prchal, MD, Hassan Yaish, MD, Archana M Agarwal, MD

Blood (2013) 122 (21): 3421.

https://doi.org/10.1182/blood.V122.21.3421.3421

Published: 2013

Journal Articles

TNT009, a Classical Complement Pathway Specific Inhibitor, Prevents Complement Dependent Hemolysis Induced By Cold Agglutinin Disease Patient Autoantibodies

Sandip Panicker, Ph.D., Ju Shi, Ph.D., Eileen Rose, Sami Hussain, Susan Tom, William Strober, Steven R. Sloan, M.D., Ph.D., Graham Parry, Ph.D., Nancy Stagliano, Ph.D.

Blood (2013) 122 (21): 42.

https://doi.org/10.1182/blood.V122.21.42.42

Published: 2013

Journal Articles

Renal Disease in Sickle Cell: Clinically Varied and Associated with Increased Mortality

Sabarish Ayyappan, MD, Paul Drawz, MD, Mehdi Nouraie, MD, Mariana E Hildesheim, Yingze Zhang, PhD, Victor R. Gordeuk, MD, Thomas H Hostetter, MD, Mark T. Gladwin, MD, Jane A Little, M.D.

Blood (2012) 120 (21): 90.

https://doi.org/10.1182/blood.V120.21.90.90

Published: 2012

Journal Articles

Role for BH3-Only Protein NOXA In Growth-Factor Deprivation and Early Erythropoiesis

Christian R. Geest, PhD, Felix M. Wensveen, PhD, Sten F.W.M. Libregts, PhD, Alex M. de Bruin, PhD, Ingrid A.M. Derks, PhD, Paul G. Ekert, Verena Labi, PhD, Andreas Villunger, PhD, Martijn A. Nolte, PhD, Eric Eldering, PhD

Blood (2010) 116 (21): 4235.

https://doi.org/10.1182/blood.V116.21.4235.4235

Published: 2010

NARROW

How I treat warm autoimmune hemolytic anemia

In Vivo reconstruction of Human Erythropoiesis with Circulating Mature Human RBCs in Humanized Liver Mistrg Mice

Inhibition of C3 with APL-2 Results in Normalisation of Markers of Intravascular and Extravascular Hemolysis in Patients with Autoimmune Hemolytic Anemia (AIHA)

Evaluating and Correcting Iron Deficit in Atypical Hemolytic Uremic Syndrome (HUS)

Short Course of Bortezomib in Anemic Patients with Refractory or Relapsed Cold Agglutinin Disease. a Phase II Prospective Study By the Gimema Group

SCD-101: A New Anti-Sickling Drug Reduces Pain and Fatigue and Improves Red Blood Cell Shape in Peripheral Blood of Patients with Sickle Cell Disease

A Selective ORAL GLYT1 Inhibitor, Improves Anemia and RED CELL Survival in a MOUSE MODEL of Beta-Thalassemia

Complement Blockade with C1 Esterase Inhibitor in Severe C3d Positive Autoimmune Hemolytic Anemia

Inflammasome-Dependent IL-1β Release from Neutrophils in Human Sickle Cell Anemia

GBT440, a Potent Anti-Sickling Hemoglobin Modifier Reduces Hemolysis, Improves Anemia and Nearly Eliminates Sickle Cells in Peripheral Blood of Patients with Sickle Cell Disease

Elevated Red Cell Microparticles (RMP) in Hematologic and Thrombotic Disorders

IgG Alloantibodies Against RBC Induced By Pregnancy or Transfusion Have Unique Glycosylation Patterns Which Correlate with Clinical Outcome of Hemolytic Disease of the Fetus or Newborn

Complement Inhibition with Eculizumab in Patients with Cold Agglutinin Disease (CAD): Results from a Prospective Phase II Trial (DECADE Trial)

End-Alveolar Carbon Monoxide As a Measure of Erythrocyte Survival and Hemolytic Severity in Sickle Cell Disease

Case Report: Autoimmune Hemolytic Anemia with Venous Thromboembolism, a Common Complication of a Rare Disease

TNT003, an inhibitor of the serine protease C1s, prevents complement activation induced by cold agglutinins

The Clinical Utility Of Next-Generation Sequencing In The Diagnosis Of Hereditary Hemolytic Anemias

TNT009, a Classical Complement Pathway Specific Inhibitor, Prevents Complement Dependent Hemolysis Induced By Cold Agglutinin Disease Patient Autoantibodies

Renal Disease in Sickle Cell: Clinically Varied and Associated with Increased Mortality

Role for BH3-Only Protein NOXA In Growth-Factor Deprivation and Early Erythropoiesis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only